This NDC is on FDA's drug shortage list (posted Jul 26, 2023)
Reported reason: Demand increase for the drug
Product Information
METHYLPHENIDATE ER 63 MG TAB is a generic product labeled by Trigen Laboratories, LLC, priced at $18.8744 per EA under NDC 13811070030. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jun 23, 2022.
Strength
63 mg/1
Manufacturer
Trigen Laboratories, LLCNDC
13811070030
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA216117FDA Approved
6/23/2022
On Market Since
6/23/2022
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER 63 MG TAB has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 6.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.8744 per EA |
|---|---|
| All-time high | $19.1883 (Jan 14, 2026) |
| All-time low | $15.5799 (Dec 18, 2024) |
| 52-week high | $19.1883 |
| 52-week low | $18.1906 |
| Median price | $17.6659 |
| Average price | $17.6453 |
| Largest weekly change | -9.4% (Dec 18, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methylphenidate hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Trigen Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER 63 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 63 MG TAB, manufactured by Trigen Laboratories, LLC, is $18.8744 per EA (NDC 13811070030), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE ER 63 MG TAB changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER 63 MG TAB has risen 6.8%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 63 MG TAB?
Since Apr 17, 2024, the NADAC for METHYLPHENIDATE ER 63 MG TAB has ranged from a low of $15.5799 (Dec 18, 2024) to a high of $19.1883 (Jan 14, 2026), with a median of $17.6659 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER 63 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of METHYLPHENIDATE ER 63 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METHYLPHENIDATE ER 63 MG TAB?
METHYLPHENIDATE ER 63 MG TAB (NDC 13811070030) is labeled by Trigen Laboratories, LLC, and CMS classifies it as a generic product.
Is METHYLPHENIDATE ER 63 MG TAB in shortage?
Yes — NDC 13811070030 is currently listed in FDA's drug shortage database (posted Jul 26, 2023). Reported reason: Demand increase for the drug.